Federated Hermes, Inc. Avid Bioservices, Inc. Transaction History

Federated Hermes, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$4.64 - $9.56 $1.49 Million - $3.07 Million	321,477 New	321,477 $2.09 Million
Q2 2022 Aug 15, 2022	SELL	$11.63 - $21.55 $13,793 - $25,558	-1,186 Reduced 44.81%	1,461 $22,000
Q1 2022 May 13, 2022	SELL	$16.63 - $27.73 $1.95 Million - $3.26 Million	-117,431 Reduced 97.8%	2,647 $54,000
Q4 2021 Feb 14, 2022	SELL	$20.7 - $34.18 $520,812 - $859,968	-25,160 Reduced 17.32%	120,078 $3.5 Million
Q3 2021 Nov 15, 2021	BUY	$19.05 - $28.32 $19,107 - $28,404	1,003 Added 0.7%	145,238 $3.13 Million
Q2 2021 Aug 16, 2021	BUY	$18.93 - $25.65 $224,206 - $303,798	11,844 Added 8.95%	144,235 $3.7 Million
Q1 2021 May 13, 2021	BUY	$11.86 - $21.77 $1.53 Million - $2.81 Million	129,126 Added 3954.85%	132,391 $2.41 Million
Q4 2020 Feb 12, 2021	BUY	$7.25 - $11.76 $23,671 - $38,396	3,265 New	3,265 $38,000

188

68.4M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.